Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Invested Capital: 2010-2025

Historic Invested Capital for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to $10.4 million.

  • ProPhase Labs' Invested Capital fell 77.24% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 77.24%. This contributed to the annual value of $12.1 million for FY2024, which is 78.20% down from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Invested Capital is $10.4 million, which was down 34.76% from $15.9 million recorded in Q2 2025.
  • ProPhase Labs' Invested Capital's 5-year high stood at $68.2 million during Q2 2022, with a 5-year trough of $10.4 million in Q3 2025.
  • For the 3-year period, ProPhase Labs' Invested Capital averaged around $40.5 million, with its median value being $50.4 million (2024).
  • As far as peak fluctuations go, ProPhase Labs' Invested Capital surged by 455.40% in 2021, and later slumped by 78.20% in 2024.
  • ProPhase Labs' Invested Capital (Quarterly) stood at $58.6 million in 2021, then grew by 8.53% to $63.6 million in 2022, then declined by 13.12% to $55.3 million in 2023, then crashed by 78.20% to $12.1 million in 2024, then tumbled by 77.24% to $10.4 million in 2025.
  • Its last three reported values are $10.4 million in Q3 2025, $15.9 million for Q2 2025, and $19.7 million during Q1 2025.